BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 17171529)

  • 1. MRI evaluation of myocardial viability.
    De Filippo M; Julsrud P; Araoz P; De Blasi M; Agnese G; Squarcia U; Ardissino D; Beghi C; Gherli T; Sverzellati N; Zompatori M
    Radiol Med; 2006 Dec; 111(8):1035-53. PubMed ID: 17171529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of myocardial viability with cardiac magnetic resonance imaging.
    Ozben B; Cinçin AA; Mutlu B
    Anadolu Kardiyol Derg; 2008 Nov; 8 Suppl 2():71-6. PubMed ID: 19028638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of myocardial viability in ischemic heart disease by cardiac magnetic resonance imaging.
    Muellerleile K; Barmeyer A; Groth M; Lund GK
    Minerva Cardioangiol; 2008 Apr; 56(2):237-49. PubMed ID: 18319702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and prognostic value of cardiac magnetic resonance imaging in assessing myocardial viability.
    Kwong RY; Korlakunta H
    Top Magn Reson Imaging; 2008 Feb; 19(1):15-24. PubMed ID: 18690157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technology insight: assessment of myocardial viability by delayed-enhancement magnetic resonance imaging.
    Judd RM; Wagner A; Rehwald WG; Albert T; Kim RJ
    Nat Clin Pract Cardiovasc Med; 2005 Mar; 2(3):150-8. PubMed ID: 16265459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of reversible myocardial dysfunction by magnetic resonance imaging.
    Fedele F; Scopinaro F; Montesano T; Di Cesare E; Di Renzi P; Vitarelli A; Dagianti A
    Herz; 1994 Aug; 19(4):210-20. PubMed ID: 7959535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging of acute myocardial ischaemia and infarction.
    Garot J
    Arch Mal Coeur Vaiss; 2003 Dec; 96(12):1213-8. PubMed ID: 15248449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of echocardiographic two-dimensional speckle tracking longitudinal strain imaging for viability assessment in patients with chronic ischemic left ventricular dysfunction and comparison with contrast-enhanced magnetic resonance imaging.
    Roes SD; Mollema SA; Lamb HJ; van der Wall EE; de Roos A; Bax JJ
    Am J Cardiol; 2009 Aug; 104(3):312-7. PubMed ID: 19616660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging in determination of myocardial ischemia and viability: comparison with positron emission tomography and single-photon emission computed tomography in a porcine model.
    Wang L; Zhu HY; Tian JM; Huang SD; Kong LS; Lu JP
    Acta Radiol; 2007 Jun; 48(5):500-7. PubMed ID: 17520425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of myocardial viability in chronic ischemic heart disease: current status.
    Rizzello V; Poldermans D; Bax JJ
    Q J Nucl Med Mol Imaging; 2005 Mar; 49(1):81-96. PubMed ID: 15724138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is postsystolic shortening a marker of viability in chronic left ventricular ischemic dysfunction? Comparison with late enhancement contrast magnetic resonance imaging.
    Lim P; Pasquet A; Gerber B; D'Hondt AM; Vancraeynest D; Guéret P; Vanoverschelde JL
    J Am Soc Echocardiogr; 2008 May; 21(5):452-7. PubMed ID: 18029142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of visual assessment in the detection and quantification of myocardial scar by delayed enhancement magnetic resonance imaging.
    Krittayaphong R; Saiviroonporn P; Boonyasirinant T; Nakyen S; Thanapiboonpol P; Udompunturak S
    J Med Assoc Thai; 2007 Nov; 90 Suppl 2():1-8. PubMed ID: 19238646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis of myocardial infarction and myocardial viability using contrast-enhanced magnetic resonance imaging].
    Mahrholdt H; Wagner A; Geissler A; Sechtem U
    Dtsch Med Wochenschr; 2002 Jun; 127(23):1264-71. PubMed ID: 12053287
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic role of dobutamine stress echocardiography in myocardial viability.
    Schinkel AF; Poldermans D; Elhendy A; Bax JJ
    Curr Opin Cardiol; 2006 Sep; 21(5):443-9. PubMed ID: 16900006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiac magnetic resonace imaging].
    Sakuma H
    Kyobu Geka; 2007 Jul; 60(8 Suppl):635-41. PubMed ID: 17763662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ["Dead or alive?": how and why myocardial viability imaging by cardiac MRI works].
    Hunold P; Kreitner KF; Barkhausen J
    Rofo; 2007 Oct; 179(10):1016-24. PubMed ID: 17594631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of myocardial viability: review of the clinical significance.
    Ramos M; DePasquale E; Coplan NL
    Rev Cardiovasc Med; 2008; 9(4):225-31. PubMed ID: 19122580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reverse-remodeling after coronary artery bypass grafting in ischemic cardiomyopathy: assessment of myocardial viability by delayed-enhanced magnetic resonance imaging can help cardiac surgeons.
    Ogawa M; Doi K; Fukumoto A; Yaku H
    Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):673-5. PubMed ID: 17670732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technology insight: MRI of the myocardium.
    Shah DJ; Judd RM; Kim RJ
    Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):597-605; quiz 606. PubMed ID: 16258572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive assessment of myocardial viability.
    Beller GA
    N Engl J Med; 2000 Nov; 343(20):1488-90. PubMed ID: 11078777
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.